Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Blood|September 15, 1996
A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemiaA Hochhaus, A Reiter, H Skladny, et al.
Blood|March 10, 2001
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, E Kanfer, R Szydlo, et al.
Bone Marrow Transplantation|June 19, 1998
Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donorsF van Rhee, D Savage, J Blackwell, et al.
Bone Marrow Transplantation|January 1, 1993
Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletionJ O Cullis, R M Szydlo, N C Cross, et al.
Blood|December 23, 1999
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemiaF Dazzi, R M Szydlo, C Craddock, et al.
Blood|February 15, 1996
Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reactionA Hochhaus, F Lin, A Reiter, et al.
Blood|August 26, 1998
Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndromeA Reiter, J Sohal, S Kulkarni, et al.
British Journal of Haematology|December 12, 2001
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapseT I Mughal, A Yong, R M Szydlo, et al.
Blood|December 23, 1999
Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study GroupA Hochhaus, A Reiter, S Saussele, et al.
Blood|August 9, 2001
A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemiaR J Jaju, C Fidler, O A Haas, et al.
Pageof 15